Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Jeffrey A. Ward"'
Autor:
Brendan Knapp, Laura Mezquita, Siddhartha Devarakonda, Mihaela Aldea, Saiama N. Waqar, Kym Pepin, Jeffrey P. Ward, Angela Botticella, Karen Howarth, Charlene Knape, Clive Morris, Ramaswamy Govindan, Benjamin Besse, Daniel Morgensztern
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionCirculating tumor DNA (ctDNA) testing may identify patients at high risk for recurrence following chemoradiation (CRT) for locally advanced non-small cell lung cancer (LA-NSCLC). We evaluated the feasibility of ctDNA testing on a readily
Externí odkaz:
https://doaj.org/article/bdec53ddcf914269b586e80415fd720d
Publikováno v:
Proceedings of the Institution of Mechanical Engineers, Part M: Journal of Engineering for the Maritime Environment. 237:370-384
A model of a hybrid marine engine exhaust gas scrubber is constructed using sea-trial data and a chemical process simulator. The model can describe the performance of the scrubber under both open-loop and closed-loop operation. Predictions for solubi
Autor:
Wei-Ting Tang, Jeffrey D. Ward
Publikováno v:
Industrial & Engineering Chemistry Research. 61:13488-13504
Autor:
Nathan W. Link, Jeffrey T. Ward
Publikováno v:
Justice Quarterly. 39:1499-1523
Publikováno v:
Industrial & Engineering Chemistry Research.
Autor:
Matthew M. Gubin, Brian T. Edelson, Ken Chen, Reshma Taneja, Josué E. Pineda, Anna M. Highsmith, Jeffrey P. Ward, Charmelle D. Williams, Ekaterina Esaulova, Sunita Keshari, Nicholas N. Jarjour, Qi Miao, Alexander S. Shavkunov, Avery J. Salmon
Immune checkpoint therapy (ICT) using antibody blockade of programmed cell death protein 1 (PD-1) or cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) can provoke T cell–dependent antitumor activity that generates durable clinical responses in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76db012299fcae59fe721ea91357eaff
https://doi.org/10.1158/2326-6066.c.6550554.v1
https://doi.org/10.1158/2326-6066.c.6550554.v1
Autor:
Matthew M. Gubin, Brian T. Edelson, Ken Chen, Reshma Taneja, Josué E. Pineda, Anna M. Highsmith, Jeffrey P. Ward, Charmelle D. Williams, Ekaterina Esaulova, Sunita Keshari, Nicholas N. Jarjour, Qi Miao, Alexander S. Shavkunov, Avery J. Salmon
Supplementary Figure from BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eab028610fe4cfde3108c6638150e4c
https://doi.org/10.1158/2326-6066.22544160
https://doi.org/10.1158/2326-6066.22544160
Autor:
Gavin P. Dunn, Robert D. Schreiber, Maxim N. Artyomov, Elaine R. Mardis, Anton Alexandrov, Yujie Fu, Diane Bender, Dale K. Kobayashi, Courtney Wilson, Christopher A. Miller, Jeffrey P. Ward, Tanner M. Johanns
The “cancer immunogenomics” paradigm has facilitated the search for tumor-specific antigens over the last 4 years by applying comprehensive cancer genomics to tumor antigen discovery. We applied this methodology to identify tumor-specific “neoa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba27932f367359567923d9b3ca7e42b5
https://doi.org/10.1158/2326-6066.c.6548734.v1
https://doi.org/10.1158/2326-6066.c.6548734.v1
Autor:
Gavin P. Dunn, Robert D. Schreiber, Maxim N. Artyomov, Elaine R. Mardis, Anton Alexandrov, Yujie Fu, Diane Bender, Dale K. Kobayashi, Courtney Wilson, Christopher A. Miller, Jeffrey P. Ward, Tanner M. Johanns
SMA-560 Composite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ccd4098cb903fe8e1de185af7c25b09
https://doi.org/10.1158/2326-6066.22538293.v1
https://doi.org/10.1158/2326-6066.22538293.v1
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Antibody blockade of programmed death-1 (PD-1) or its ligand, PD-L1, has led to unprecedented therapeutic responses in certain tumor-bearing individuals, but PD-L1 expression's prognostic value in stratifying cancer patients for such treatment remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499ace0d0a9694d639e0c27216094086
https://doi.org/10.1158/2326-6066.c.6548426.v1
https://doi.org/10.1158/2326-6066.c.6548426.v1